New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
18:41 EDTPOST, LULU, NVDA, UBNT, MELI, SLXP, CPST, MNST, MDVN, LRAD, ZNGA, TKMR, SCTY, ANET, FOLDOn The Fly: After Hours Movers
UP AFTER EARNINGS: MercadoLibre (MELI), up 14.2%... Amicus Therapeutics (FOLD), up 10.5%... LRAD Corporation (LRAD), up 18%... Ubiquiti Networks (UBNT), up 7%... Arista Networks (ANET), up 8.8%... Medivation (MDVN), up 4.2%... NVIDIA (NVDA), up 4.5%... SolarCity (SCTY), up 4.6%... Monster Beverage (MNST), up 2.5%. ALSO HIGHER: Lululemon Athletica (LULU), up 5.7% following announcement that founder Chip Wilson will sell half his stake to Advent International... Tekmira Pharmaceuticals (TKMR), up 7.2% after announcing that the FDA verbally confirmed they have modified the full clinical hold placed on the TKM-Ebola to a partial clinical hold. DOWN AFTER EARNINGS: Capstone Turbine (CPST), down 12%... Post Holdings (POST), down 13.1% after reporting quarterly results and that it acquired American Blanching for $128M in cash... Zynga (ZNGA), down 7.2% after lowering fiscal 2014 guidance... Salix Pharmaceuticals (SLXP), down 3.4%.
News For MELI;FOLD;LRAD;UBNT;ANET;MDVN;NVDA;SCTY;MNST;LULU;TKMR;CPST;POST;ZNGA;SLXP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
May 11, 2015
07:26 EDTNVDAQualcomm rivals questioned by EU antitrust regulators, Reuters reports
Antitrust regulators in the EU are asking Qualcomm's (QCOM) rivals about the company's business practices, Reuters reports, citing a document. Europe has been investigating Qualcomm for the last seven months over the way it licenses its products and its power over patents. Another EU inquiry, which began in 2010, was triggered by a complained from Nvidia's (NVDA) Icera unit over rebates and incentives. Reference Link
06:21 EDTPOSTPost Holdings downgraded to Neutral from Buy at Citigroup
Subscribe for More Information
06:19 EDTMNSTMonster Beverage upgraded to Buy from Neutral at Citigroup
Subscribe for More Information
06:13 EDTANETArista Networks received certification of Arista Cloud with ServiceNow
Subscribe for More Information
May 8, 2015
11:57 EDTNVDANVIDIA shares lower after reporting Q1 results amid soft PC demand
Subscribe for More Information
10:25 EDTUBNTOptions with decreasing implied volatility
Subscribe for More Information
10:13 EDTNVDANVIDIA falls after earnings
Subscribe for More Information
10:03 EDTMNSTHigh option volume stocks
Subscribe for More Information
10:01 EDTUBNT, MNST, NVDAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTMNSTMonster Beverage drops after earnings
The stock was last down over 10% to $128.66. At that price, next support is at $126. Resistance is at $130.05.
09:28 EDTMNSTOn The Fly: Pre-market Movers
Subscribe for More Information
08:06 EDTNVDANVIDIA downgraded to Neutral from Buy at Roth Capital
Roth Capital downgraded NVIDA to Neutral from Buy and lowered its price target to $22 from $26. NVIDIA reported Q1 results below Roth's estimates and provided a cautious near-term outlook. Roth lowered estimates due to weak PC OEM low/mid-range graphics demand and weak Tegra mobile demand, combined with macro weakness and FX issues impacting enterprise workstation demand.
07:48 EDTMNSTMonster Beverage sales growth likely to accelerate in Q2, says Stifel
Subscribe for More Information
07:44 EDTLULUFriction between lululemon board, founder may flare up again, WSJ says
Subscribe for More Information
07:36 EDTUBNTUbiquiti Networks downgraded to Neutral from Buy at SunTrust
Subscribe for More Information
07:15 EDTMDVNMedivation price target raised to $142 from $130 at UBS
Subscribe for More Information
07:12 EDTUBNTUbiquiti Networks downgraded to Neutral from Buy at SunTrust
Subscribe for More Information
06:59 EDTMDVNMedivation weakness a buying opportunity, says William Blair
William Blair recommends using the post-earnings weakness in shares of Medivation as a buying opportunity. The firm believes Xtandi sales growth in prostate cancer remains strong despite the Q1 miss and raised its price target for shares to $154 from $144. It keeps an Outperform rating on the name.
06:43 EDTMNSTMonster Beverage downgraded to Neutral from Conviction Buy at Goldman
Goldman Sachs downgraded Monster Beverage to Neutral from Conviction Buy citing more limited upside potential following the recent rally in shares. Goldman still views Monster's deal with Coca-Cola (KO) as transformational, but points out it is taking longer than expected. The firm has a $150 price target for Monster shares
06:22 EDTUBNTUbiquiti Networks downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use